What is a typical LDL-C goal for patients with very high-risk ASCVD?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

What is a typical LDL-C goal for patients with very high-risk ASCVD?

Lowering LDL-C to very low levels in patients with established ASCVD who are at very high risk meaningfully reduces recurrent cardiovascular events. That’s why the best choice is the most aggressive LDL-C target among typical goals for this group. Achieving that deep reduction usually starts with a high-intensity statin, and if the goal isn’t reached, ezetimibe is added. If LDL-C remains above goal, consider additional therapies such as PCSK9 inhibitors to push the level even lower. The other options reflect less aggressive targets and don’t provide the same level of risk reduction in this very high-risk population. Tailor the plan to the patient’s tolerance and comorbidities, and follow current guidelines as they evolve.

Lowering LDL-C to very low levels in patients with established ASCVD who are at very high risk meaningfully reduces recurrent cardiovascular events. That’s why the best choice is the most aggressive LDL-C target among typical goals for this group. Achieving that deep reduction usually starts with a high-intensity statin, and if the goal isn’t reached, ezetimibe is added. If LDL-C remains above goal, consider additional therapies such as PCSK9 inhibitors to push the level even lower. The other options reflect less aggressive targets and don’t provide the same level of risk reduction in this very high-risk population. Tailor the plan to the patient’s tolerance and comorbidities, and follow current guidelines as they evolve.

More practice questions